NMAX:NYSENewsmax, Inc. Analysis
Data as of 2026-04-20 - not real-time
$6.95
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Newsmax, Inc. is trading below its short‑term moving averages, signaling a bearish technical backdrop despite a modestly positive RSI and a bullish MACD histogram. Volume is on a downtrend, and the stock sits near the upper end of its recent support‑resistance range, with the 30‑day volatility soaring well above market averages. The company’s fundamentals are weak: earnings are negative, margins are in the red, and cash flow is sharply negative, while valuation multiples such as price‑to‑earnings and price‑to‑book are dramatically above industry norms.
The recent appointment of a seasoned finance executive to the board underscores a strategic push into streaming and digital platforms, but the immediate financial picture remains challenged. With a high beta and extreme‑greed market sentiment, the stock faces significant upside‑downside potential, yet the current technical and fundamental signals suggest caution.
The recent appointment of a seasoned finance executive to the board underscores a strategic push into streaming and digital platforms, but the immediate financial picture remains challenged. With a high beta and extreme‑greed market sentiment, the stock faces significant upside‑downside potential, yet the current technical and fundamental signals suggest caution.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below short‑term moving averages
- Decreasing volume and high short‑term volatility
- Negative earnings and cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Potential upside from streaming expansion
- Continued pressure from weak profitability
- Elevated beta amplifying market swings
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strategic board appointment may improve execution
- Fundamental turnaround required for sustainable growth
- High valuation multiples limit upside without earnings improvement
Key Metrics & Analysis
Financial Health
Revenue Growth9.60%
Profit Margin-52.57%
P/E Ratio99.3
ROE-205.18%
ROA-32.34%
Debt/Equity8.82
P/B Ratio8.5
Op. Cash Flow$-104454880
Free Cash Flow$-113280184
Industry P/E19.3
Technical Analysis
TrendBearish
RSI61.8
Support$5.11
Resistance$7.10
MA 20$6.06
MA 50$6.26
MA 200$9.75
MACDBullish
VolumeDecreasing
Fear & Greed Index86.98
Valuation
Target Price$18.50
Upside/Downside166.19%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.45
Volatility70.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.